Buy Azulfidine
Azulfidine

$0.85
Delivery
Airmail (14-21 days) | EMS trackable (5-9 days)
Prescription
Issued on site / Included
Availability
In Stock
Product is shipped in a fully discreet envelope with no content disclosure, including all required documentation inside

Azulfidine Properties

Active Ingredients
Primary Category
Pharmacological Class
Aminosalicylate and Sulfonamide Derivative
Minor Side Effects
Moderate Side Effects
Dosage Forms
Tablets
Administration Route
Oral
Mechanism of Action
Reduced inflammation in the bowel and joints. Its active components are released in the gut and act locally.
Prescription Status
Rx
Patient Summary
Used to reduce inflammation and symptoms in certain bowel conditions and a type of arthritis.
Onset Time
Effects may take weeks to months
Duration
Requires regular dosing
Storage Instructions
Store at room temperature, away from moisture
Pregnancy Use
Consult doctor before use during pregnancy
Alternative Drugs

About Azulfidine

Azulfidine (sulfasalazine) is a prescription medication approved for the treatment of chronic inflammatory conditions such as ulcerative colitis and rheumatoid arthritis. It belongs to the class of disease-modifying antirheumatic drugs (DMARDs) and works by delivering an anti-inflammatory compound directly to the gut while also modulating immune activity systemically. In Singapore the drug is available as a 500 mg oral tablet that patients take under medical supervision.


What is Azulfidine?

Azulfidine is a brand-name formulation that contains the active ingredient sulfasalazine, a sulfonamide-linked compound originally developed in the -s to treat inflammatory bowel disease. The product is marketed as a pill, typically 500 mg per tablet, and is classified as a prescription medication. Although several manufacturers produce sulfasalazine worldwide, Azulfidine is sold under its own trade name and is not tied to a single internationally recognised company in the Singapore market.

In regulatory terms, the Singapore Health Sciences Authority (HSA) lists sulfasalazine as a prescription-only medicine, reflecting its need for professional monitoring due to potential adverse reactions and required dose titration. The drug is considered a DMARD because it alters the underlying disease process rather than merely relieving symptoms.


How Azulfidine Works

Sulfasalazine is a pro-drug composed of two parts: 5-aminosalicylic acid (5-ASA) and sulfapyridine, joined by an azo bond. After oral ingestion, the tablet remains largely intact as it passes through the stomach and small intestine, where bacterial enzymes are scarce. Once the compound reaches the colon, resident bacteria cleave the azo linkage, releasing 5-ASA and sulfapyridine locally.

5-ASA exerts its anti-inflammatory effect by inhibiting cyclo-oxygenase and lipoxygenase pathways, which reduces the production of prostaglandins and leukotrienes-key mediators of inflammation in the gut lining. It also dampens the activity of nuclear factor-κB (NF-κB), a transcription factor that drives the expression of numerous inflammatory genes.

Sulfapyridine is absorbed into the systemic circulation and modulates immune responses by suppressing T-cell activation and limiting the production of cytokines such as tumor-necrosis factor-α (TNF-α). This systemic action contributes to the drug’s efficacy in rheumatoid arthritis, where joint inflammation is driven by an over-active immune system.

Pharmacokinetically, sulfasalazine has a relatively slow onset. Clinical improvement in ulcerative colitis often appears after 2-4 weeks of therapy, while benefits for rheumatoid arthritis may require 6-8 weeks. The drug is partially metabolised in the liver and excreted via the kidneys; its half-life ranges from 8 to 10 hours for the sulfapyridine moiety, necessitating once- or twice-daily dosing to maintain therapeutic levels.


Why Azulfidine is Used for Inflammatory Conditions

  • Ulcerative colitis - The colon-targeted release of 5-ASA directly addresses the mucosal inflammation that characterises this disease. By limiting prostaglandin synthesis locally, the drug reduces ulcer formation and rectal bleeding. Clinical guidelines from the American College of Gastroenterology recommend sulfasalazine as a first-line option for mild-to-moderate disease, especially when patients prefer an oral therapy over rectal preparations.

  • Rheumatoid arthritis - Sulfapyridine’s systemic immunomodulation slows joint damage by curbing the activity of inflammatory cytokines. Randomised trials have shown that patients receiving sulfasalazine experience fewer swollen joints and lower erosive progression than those on placebo, supporting its inclusion in combination DMARD regimens.

  • Psoriatic arthritis - Although not a primary indication, the drug’s ability to suppress TNF-α makes it useful for patients whose skin disease co-exists with joint inflammation. Small cohort studies have reported modest reductions in joint pain and skin lesions when sulfasalazine is added to standard therapy.

  • Ankylosing spondylitis - Off-label use in axial spondyloarthritis stems from the same cytokine-blocking mechanism. Some rheumatology societies cite sulfasalazine as a secondary option when patients cannot tolerate first-line biologics.

In each of these conditions, the central theme is the drug’s dual action: local anti-inflammatory effects in the gut and broader immune suppression that protects joints and connective tissue.


Off-Label and Investigational Uses of Azulfidine

Beyond its approved indications, sulfasalazine has been explored for several inflammatory and autoimmune disorders. Small-scale studies suggest benefit in chronic uveitis, where the anti-inflammatory properties may reduce ocular flare-ups. Researchers have also investigated its role in early-stage Crohn’s disease; however, the drug’s limited colonic activation renders it less effective than agents designed for small-bowel disease.

Occasionally, dermatologists prescribe sulfasalazine for severe hidradenitis suppurativa when conventional antibiotics fail, relying on its capacity to dampen neutrophil-mediated inflammation.

Off-label use only under qualified healthcare provider supervision.


Is Azulfidine Right for You?

Patients who require long-term control of intestinal inflammation or joint disease often find sulfasalazine a valuable component of their therapeutic plan. Ideal candidates are adults with confirmed ulcerative colitis or rheumatoid arthritis who have not responded adequately to first-line agents such as mesalamine or NSAIDs.

Individuals with a known sulfonamide allergy should avoid the medication, as cross-reactivity can provoke severe skin reactions. Those with significant hepatic or renal impairment may require dose adjustments or alternative therapies because sulfasalazine and its metabolites are cleared through these organs. Pregnant or breastfeeding women should discuss risks with their obstetrician, since limited safety data exist.

Conversely, patients with mild disease that can be managed with topical agents may not need the systemic exposure that Azulfidine entails. The decision hinges on a balance between disease severity, comorbid conditions, and patient preference regarding oral versus injectable therapies.


Taking Azulfidine Effectively

When initiating therapy, clinicians usually start with a low dose-often one 500 mg tablet daily-to gauge tolerance. The dosage is then gradually increased, sometimes to two or three tablets per day, based on clinical response and laboratory monitoring. Taking the tablet with food can lessen gastrointestinal upset, a frequent early-stage complaint.

Because sulfasalazine is activated by colonic bacteria, the drug should be swallowed whole; crushing or chewing may reduce efficacy. If a dose is missed, the recommendation is to take it as soon as it is remembered, provided the next scheduled dose is at least six hours away. Doubling up is discouraged, as higher peaks increase the risk of nausea and headache.

Laboratory tests-complete blood count, liver enzymes, and renal function-are typically ordered every 2-4 weeks during the titration phase, then periodically thereafter. These checks help detect early signs of bone-marrow suppression or hepatotoxicity, allowing timely dose modification.

Lifestyle measures that complement pharmacotherapy include a balanced diet rich in fiber, regular low-impact exercise, and smoking cessation, all of which can improve gastrointestinal and joint outcomes. Patients should also maintain a medication diary or set smartphone reminders to support adherence.


Understanding Side Effects and How to Manage Them

Side effects arise largely from the sulfapyridine component, which can irritate the gastrointestinal tract and affect blood cell production. Common complaints include mild nausea, abdominal discomfort, and transient headache. These often diminish as the body adapts to the medication; taking the tablet with meals and staying hydrated can alleviate discomfort.

Increased photosensitivity is a recognized risk, meaning patients should use sunscreen and wear protective clothing when outdoors for prolonged periods. If a rash develops-especially one that spreads or becomes blistered-contacting a healthcare provider promptly is essential, as this may signal a hypersensitivity reaction.

Rare but serious adverse events involve hematologic suppression (e.g., leukopenia, thrombocytopenia) and hepatic injury. Warning signs include unexplained fever, persistent fatigue, dark urine, or jaundice. Should any of these occur, medical attention is required immediately; discontinuation of the drug is usually necessary.

Kidney stones can form due to sulfapyridine metabolites. Maintaining adequate fluid intake-at least 2 liters of water daily-helps reduce this risk. Patients with a history of gout should inform their physician, as sulfasalazine can raise uric acid levels.

Overall, vigilant monitoring and open communication with the prescribing clinician enable most side effects to be managed without discontinuing therapy.


Buying Azulfidine from Our Online Pharmacy

Why Choose Our Service?

Our online pharmacy provides a discreet, cost-effective pathway to obtain Azulfidine when local pharmacies face supply constraints or higher retail prices.

Quality & Safety

We partner with licensed international pharmacies that adhere to stringent regulatory standards imposed by health authorities such as the U.S. FDA, EMA, and Singapore HSA. All products undergo authentication checks to confirm batch integrity and expiry dates before shipment.

Pricing & Access

Because the medication is sourced directly from manufacturers’ authorized distributors, the price you pay approaches the wholesale cost, delivering savings of up to 30 % compared with brick-and-mortar outlets. If you prefer a generic alternative, we also stock sulfasalazine tablets marketed under other brand names, offering additional flexibility.

Discreet Delivery

Orders are packed in unmarked, bubble-wrapped envelopes to protect privacy. Standard airmail arrives within three weeks, while express shipping reaches most Singapore addresses in about seven days. Tracking information is provided at each stage of transit.


Frequently Asked Questions

  • How long does it take to notice improvement in ulcerative colitis? Most patients report a reduction in stool frequency and bleeding after 2-4 weeks of consistent dosing. Full remission may require 8-12 weeks, especially when the dose is being escalated.

  • Can I take Azulfidine if I have a mild sulfa allergy? Even a mild sulfonamide hypersensitivity can precipitate a severe reaction to sulfasalazine. Discuss the nature of your allergy with a clinician; an alternative DMARD may be safer.

  • What laboratory tests are needed while on this medication? Baseline blood counts, liver enzymes, and renal function are obtained before starting therapy. Follow-up testing is typically performed every 2-4 weeks during dose titration, then every 3-6 months once stabilized.

  • Is it safe to use Azulfidine while breastfeeding? Small amounts of sulfasalazine and its metabolites appear in breast milk. Current guidance advises caution; a physician may recommend an alternative if the infant is premature or has health concerns.

  • Can I combine Azulfidine with other DMARDs? Yes, sulfasalazine is often paired with methotrexate or hydroxychloroquine in a “triple therapy” regimen for rheumatoid arthritis. Combination therapy can enhance efficacy but requires close monitoring for additive toxicity.

  • What should I do if I miss a dose? Take the missed tablet as soon as you remember, provided the next scheduled dose is at least six hours away. If it is closer, skip the missed dose and resume your regular schedule; do not double up.

  • Does food affect the absorption of sulfasalazine? The drug’s activation occurs in the colon, so food does not significantly alter its bioavailability. However, taking the tablet with meals can lessen stomach upset.

  • Are there any dietary restrictions while taking Azulfidine? No specific restrictions exist, but maintaining adequate hydration helps reduce the risk of kidney stones. Patients with gout may need to limit purine-rich foods because sulfasalazine can modestly raise uric acid levels.

  • How does sulfasalazine differ from other 5-ASA agents? Unlike mesalamine, which is fully released in the colon, sulfasalazine delivers both 5-ASA and sulfapyridine. This dual action provides systemic immune modulation, making it useful for joint disease as well as colitis.

  • Can I travel abroad with my prescription? Carry a copy of the prescribing information and a letter from your doctor. Singapore’s Health Sciences Authority permits personal import of a 30-day supply for travelers, provided the medication is for a legitimate medical condition.

  • What happens if I become pregnant while on Azulfidine? The medication is classified as pregnancy category B in many jurisdictions, indicating no proven fetal risk in animal studies but insufficient human data. Discuss potential benefits and risks with your obstetrician before making any changes.


Glossary

Azo bond
A chemical linkage between two aromatic rings that is cleaved by bacterial enzymes in the colon, releasing active drug components.
Cyclo-oxygenase (COX)
An enzyme that converts arachidonic acid into prostaglandins, mediators that promote inflammation, pain, and fever.
Nuclear factor-κB (NF-κB)
A protein complex that regulates the transcription of DNA, playing a central role in immune and inflammatory responses.
Sulfonamide allergy
An immune-mediated hypersensitivity to drugs containing the sulfonamide group, which can manifest as rash, fever, or anaphylaxis.
Disease-modifying antirheumatic drug (DMARD)
A class of medications that slow or halt the progression of autoimmune joint diseases rather than merely relieving symptoms.

Disclaimer

The information provided about Azulfidine is for general knowledge only. It does not replace professional medical consultation. All treatment decisions, including those regarding off-label use, should be made under the supervision of a qualified healthcare provider. We assume all readers are responsible adults capable of making informed decisions about their health. Our online pharmacy offers access to Azulfidine for individuals who may have limited availability through traditional pharmacies, prescription-based insurance schemes, or who are seeking affordable generic alternatives. Always consult your doctor before starting, changing, or discontinuing any medication.

External Resources about Azulfidine


Information Prepared By

Nawin Kittisak
Vikneswaran V Paranjothy